Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine

Documenti analoghi

• Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells
  di: Kwilas, Anna R, et al.
  Pubblicazione: (2014)
• Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway
  di: Ardiani, Andressa, et al.
  Pubblicazione: (2014)
• Androgen deprivation therapy increases the sensitivity of human prostate carcinoma cells to T cell-mediated lysis through an androgen receptor dependent mechanism
  di: Gameiro, Sofia, et al.
  Pubblicazione: (2014)
• Modulation of cabozantinib efficacy by the prostate tumor microenvironment
  di: Tripathi, Manisha, et al.
  Pubblicazione: (2017)
• Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack
  di: Grenga, Italia, et al.
  Pubblicazione: (2015)